Author

Inan Olmez

Virginia Commonwealth UniversityORCID 0000-0002-7153-4259Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Dawit Gebremichael AregawiiD· 1 shared Hanif KhaniD· 1 shared Hannah ValensiiD· 1 shared Jeongwu LeeiD· 1 shared M. J. Glantz· 1 shared Mitchell X. MachtayiD· 1 shared Pierre GiglioiD· 1 shared Şeyma DemirsoyiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Dawit Gebremichael AregawiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BNIP3-mTOR Signaling Mediates Resistance to MET Inhibition in Glioblastoma

Yunzhan Li, Hanif Khan, Şeyma Demirsoy, William Bernhardt, Hannah Valensi, Jeongwu Lee, Mitchell X. Machtay, Dawit Gebremichael Aregawi, M. J. Glantz, Pierre Giglio, Shengyu Yang, Todd D. Schell, Vonn Walter, Yasin Uzun, Inan Olmez

This study identifies the BNIP3-mTOR signaling axis as a mediator of resistance to MET inhibition in glioblastoma and shows that combined MET and mTOR inhibition synergistically enhances anti-tumor effects.

bioRxiv · Dec 29, 2025 · PreprintCancer Biology